InvestorsHub Logo
Followers 8
Posts 440
Boards Moderated 0
Alias Born 04/02/2013

Re: None

Saturday, 01/11/2014 11:40:14 AM

Saturday, January 11, 2014 11:40:14 AM

Post# of 424438
I think the 8k is just worst case scenario planning or sand bagging. I don't think they know about what fda is planning and if they did they would obviously be trading or planning on inside information which is not legal. With all that has happened to them, I would say they are being more conservative in their strategic plans and doing their best tie down management team to execute. Original incentive was done with joe z still in control, this has possibly now included jts input which could probably be more conservative due to his finance background. There is a big difference in how a sales guy projects a goal (obviously and usually very optimistic) and a finance guy projects is my point.

Let's keep pushing and Glta.....short % drop is nice....thinking a lot of folks including those who are not long have moved on to other things they can short just like many left being long and moved on. A partner is still the best solution IMHO. Anchor or what not, if they boost sales they will be golden. All else is gravy. If gsk can sell $1b of lovaza without an anchor type indication then we can with a much better drug. I don't believe they can do it on their own and need a lot more help. A drug can't always sell itself without people knowing about it. If they got reduce it with positive cvd outcome everyone would know about it is my point.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News